These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23339402)

  • 41. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
    De Clercq E
    Clin Microbiol Rev; 2003 Oct; 16(4):569-96. PubMed ID: 14557287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
    Luo M; Groaz E; Andrei G; Snoeck R; Kalkeri R; Ptak RG; Hartman T; Buckheit RW; Schols D; De Jonghe S; Herdewijn P
    J Med Chem; 2017 Jul; 60(14):6220-6238. PubMed ID: 28682067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
    Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.
    Magee WC; Aldern KA; Hostetler KY; Evans DH
    Antimicrob Agents Chemother; 2008 Feb; 52(2):586-97. PubMed ID: 18056278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
    Cundy KC
    Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
    Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
    Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
    Bischofberger N; Hitchcock MJ; Chen MS; Barkhimer DB; Cundy KC; Kent KM; Lacy SA; Lee WA; Li ZH; Mendel DB
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin.
    Lipka E; Chadderdon AM; Harteg CC; Doherty MK; Simon ES; Domagala JM; Reyna DM; Hutchings KM; Gan X; White AD; Hartline CB; Harden EA; Keith KA; Prichard MN; James SH; Cardin RD; Bernstein DI; Spencer JF; Tollefson AE; Wold WSM; Toth K
    Mol Pharm; 2023 Jan; 20(1):370-382. PubMed ID: 36484496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
    Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
    Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
    Andrei G; Snoeck R; Schols D; De Clercq E
    Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures.
    Lebeau I; Andrei G; Dal Pozzo F; Beadle JR; Hostetler KY; De Clercq E; van den Oord J; Snoeck R
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2525-9. PubMed ID: 16801436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
    Fu XZ; Jiang SH; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
    Chavez-de la Paz E; Arevalo JF; Kirsch LS; Munguia D; Rahhal FM; De Clercq E; Freeman WR
    Ophthalmology; 1997 Mar; 104(3):539-44. PubMed ID: 9082286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stability of cidofovir in extemporaneously prepared syringes.
    Hennere G; Havard L; Bonan B; Prognon P
    Am J Health Syst Pharm; 2005 Mar; 62(5):506-9. PubMed ID: 15745914
    [No Abstract]   [Full Text] [Related]  

  • 57. The Holý Trinity: the acyclic nucleoside phosphonates.
    De Clercq E
    Adv Pharmacol; 2013; 67():293-316. PubMed ID: 23886004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of kinase bypass strategies to nucleoside antivirals.
    Ray AS; Hostetler KY
    Antiviral Res; 2011 Nov; 92(2):277-91. PubMed ID: 21878354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
    Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor potential of acyclic nucleoside phosphonates.
    De Clercq E; Andrei G; Balzarini J; Hatse S; Liekens S; Naesens L; Neyts J; Snoeck R
    Nucleosides Nucleotides; 1999; 18(4-5):759-71. PubMed ID: 10432678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.